OssiFi Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $25.5M

OssiFi Therapeutics General Information

Description

Developer of graft substitutes designed to stimulate bone density and reduce the rate of resorption. The company develops multiple small-molecule sclerostin inhibitors to be used orally for bone disease or surgically for spinal fusion in combination with bone graft, which are inexpensive to synthesize, stable, and amenable to a wide variety of formulations compared with orthobiologics, enabling doctors to offer a cost-effective and stable treatment option.

Contact Information

Website
www.ossifi.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 11235 Mastin Street
  • Suite 102
  • Overland Park, KS 66210
  • United States
+1 (816)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Medical Supplies
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 11235 Mastin Street
  • Suite 102
  • Overland Park, KS 66210
  • United States
+1 (816)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OssiFi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 11-Feb-2026 $25.5M In Progress Stealth
5. Secondary Transaction - Private Completed Generating Revenue
4. Later Stage VC 15-Nov-2021 Completed Pre-Clinical Trials
3. Later Stage VC (Series A) 06-Nov-2018 Completed Generating Revenue
2. Later Stage VC 03-Apr-2017 $457K $2.26M Completed Generating Revenue
1. Seed Round 04-Oct-2014 $1.8M $1.8M Completed Startup
To view OssiFi Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OssiFi Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of graft substitutes designed to stimulate bone density and reduce the rate of resorption. The company develop
Drug Discovery
Overland Park, KS
3 As of 2026

Thousand Oaks, CA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OssiFi Therapeutics Competitors (2)

One of OssiFi Therapeutics’s 2 competitors is Amgen, a Formerly PE-Backed company based in Thousand Oaks, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA
Medtronic Corporation Minneapolis, MN
You’re viewing 2 of 2 competitors. Get the full list »

OssiFi Therapeutics Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

OssiFi Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014153203-A2 Alkyl-amine harmine derivatives for promoting bone growth Inactive 14-Mar-2013
WO-2014153203-A3 Alkyl-amine harmine derivatives for promoting bone growth Inactive 14-Mar-2013
US-20100092559-A1 Boldine compounds for promoting bone growth Active 02-Oct-2008
US-8188065-B2 Boldine compounds for promoting bone growth Inactive 02-Oct-2008
US-20120301509-A1 Boldline compounds for promoting bone growth Active 02-Oct-2008 A61K31/16
To view OssiFi Therapeutics’s complete patent history, request access »

OssiFi Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

OssiFi Therapeutics FAQs

  • When was OssiFi Therapeutics founded?

    OssiFi Therapeutics was founded in 2011.

  • Where is OssiFi Therapeutics headquartered?

    OssiFi Therapeutics is headquartered in Overland Park, KS.

  • What is the size of OssiFi Therapeutics?

    OssiFi Therapeutics has 3 total employees.

  • What industry is OssiFi Therapeutics in?

    OssiFi Therapeutics’s primary industry is Drug Discovery.

  • Is OssiFi Therapeutics a private or public company?

    OssiFi Therapeutics is a Private company.

  • What is the current valuation of OssiFi Therapeutics?

    The current valuation of OssiFi Therapeutics is .

  • What is OssiFi Therapeutics’s current revenue?

    The current revenue for OssiFi Therapeutics is .

  • How much funding has OssiFi Therapeutics raised over time?

    OssiFi Therapeutics has raised $18.8M.

  • Who are OssiFi Therapeutics’s competitors?

    Amgen and Medtronic are competitors of OssiFi Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process